Cargando…
COVID-19 INDUCED CARDIOMYOPATHY SUCCESSFULLY TREATED WITH TOCILIZUMAB
Autores principales: | Fakhra, Sadaf, Schreiber, Ariyon, Lei, KaChon, Sossou, Christoph, Ahsan, Chowdhury |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972517/ http://dx.doi.org/10.1016/S0735-1097(22)03364-2 |
Ejemplares similares
-
COVID-19 Induced Cardiomyopathy Successfully Treated with Tocilizumab
por: Schreiber, Ariyon, et al.
Publicado: (2022) -
Bidirectional Ventricular Tachycardia with Stress-Induced Cardiomyopathy
por: Schreiber, Ariyon, et al.
Publicado: (2022) -
TCT-64 Racial Differences and In-Hospital Mortality Associated With Stress-Induced Cardiomyopathy During the COVID-19 Pandemic
por: Khetarpal, Banveet Kaur, et al.
Publicado: (2021) -
POST-OPERATIVE MANAGEMENT AFTER CARDIAC SURGICAL REVASCULARIZATION IN A COVID-19 POSITIVE PATIENT
por: Fakhra, Sadaf, et al.
Publicado: (2022) -
VENTRICULAR SEPTAL DEFECT AFTER MYOCARDIAL INFARCTION: WHEN TO NOT STAY AT HOME DURING THE COVID-19 PANDEMIC
por: Khetarpal, Banveet Kaur, et al.
Publicado: (2022)